Articles

ACC HRS Appropriate Use Criteria ICDs CRTs

The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty societies, released appropriate use criteria for implantable cardioverter-defibrillators (ICDs)...

Weight Loss American College of Cardiology ICD Implants Risk

Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D...

Zoll wearable defibrillator

Oklahoma Heart Hospital (OHH), Oklahoma’s first dedicated heart hospital, has excelled at creating quality outcomes through an integrated approach to patient care. To maintain this culture of...

Heart Failure Treatments EP Lab ICDs JAMA Internal Medicine St. Louis University

New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat...

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD...

My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With collaboration from my Editorial Advisory Board, we developed a 2013...

The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN). The secure, Internet-based remote care system is for...

The U.S. Food and Drug Administration (FDA) in October granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world’s first commercially available subcutaneous ...

Boston Scientific Clinical Trial Implantable Cardioverter Defibrillator

November 12, 2012 — Boston Scientific Corp. and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce...

The S-ICD System is the world's first subcutaneous implantable defibrilator

The U.S. Food and Drug Administration (FDA) has granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world's first commercially available subcutaneous ...